Display options
Cite
Consolaro A, Ruperto N, Filocamo G, et al. Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study. Pediatr Rheumatol Online J. 2012;10(1):39doi: 10.1186/1546-0096-10-39.
Consolaro, A., Ruperto, N., Filocamo, G., Lanni, S., Bracciolini, G., Garrone, M., Scala, S., Villa, L., Silvestri, G., Tani, D., Zolesi, A., Martini, A., Ravelli, A. (2012). Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study. Pediatric rheumatology online journal, 10(1), 39. https://doi.org/10.1186/1546-0096-10-39
Consolaro, Alessandro, et al. "Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study." Pediatric rheumatology online journal vol. 10,1 (2012): 39. doi: https://doi.org/10.1186/1546-0096-10-39
Consolaro A, Ruperto N, Filocamo G, Lanni S, Bracciolini G, Garrone M, Scala S, Villa L, Silvestri G, Tani D, Zolesi A, Martini A, Ravelli A. Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study. Pediatr Rheumatol Online J. 2012 Nov 20;10(1):39. doi: 10.1186/1546-0096-10-39. PMID: 23164467; PMCID: PMC3551702.
Copy Download .nbib Format: NLM
Share it on

Pediatr Rheumatol Online J. 2012 Nov 20;10(1):39. doi: 10.1186/1546-0096-10-39.

Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study.

Pediatric rheumatology online journal

Alessandro Consolaro, Nicolino Ruperto, Giovanni Filocamo, Stefano Lanni, Giulia Bracciolini, Marco Garrone, Silvia Scala, Luca Villa, Giuseppe Silvestri, Daniela Tani, Alessandra Zolesi, Alberto Martini, Angelo Ravelli,

Affiliations

  1. Istituto Giannina Gaslini, Genova, Italy. [email protected].

PMID: 23164467 PMCID: PMC3551702 DOI: 10.1186/1546-0096-10-39

Abstract

The epidemiology of juvenile idiopathic arthritis (JIA) is variable worldwide. In particular, a wide disparity exists in the prevalence of the diverse disease subtypes across different geographic areas. The therapeutic approach to JIA is not standardized and no established and widely accepted guidelines are available. In the past decade, there have been important progresses in the management of the disease, but the availability of the novel and costly biologic medications is not uniform throughout the world. This issue may have significant impact on disease prognosis, with children living in poorer countries being at greater risk of accumulating disease- and treatment-related damage than children followed in Western pediatric rheumatology centers. The multinational study of the EPidemiology, treatment and Outcome of Childhood Arthritis (EPOCA study) is aimed to obtain information on the frequency of JIA subtypes in different geographic areas, the therapeutic approaches adopted by pediatric rheumatologists practicing in diverse countries or continents, and the disease and health status of children with JIA currently followed worldwide. Parent- and child-reported outcomes are meant to be recorded through the administration of a new multidimensional questionnaire, the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). The first step of the study is based on the translation and cross-cultural adaptation of the questionnaire in the national language of each participating country. Each center is, then, asked to enroll a sample of consecutive JIA patients, who should undergo a retrospective assessment and a cross-sectional evaluation, including completion of the JAMAR, a standardized joint examination, and the assessment of articular and extra-articular damage. At the end of May 2012, 124 centers in 55 countries have agreed to participate in the study. The JAMAR has been or is currently being translated in 38 national languages. The target patient sample is more than 10,000 JIA children worldwide.

References

  1. Arthritis Rheum. 2007 Aug 15;57(6):913-20 - PubMed
  2. Best Pract Res Clin Rheumatol. 2006 Apr;20(2):279-300 - PubMed
  3. J Rheumatol. 2002 Jul;29(7):1520-30 - PubMed
  4. Arthritis Care Res (Hoboken). 2010 Jun;62(6):857-64 - PubMed
  5. Rheumatology (Oxford). 2010 Jul;49(7):1272-80 - PubMed
  6. J Rheumatol. 2012 Apr;39(4):856-63 - PubMed
  7. Clin Exp Rheumatol. 1999 May-Jun;17(3):367-74 - PubMed
  8. J Rheumatol. 2010 Jul;37(7):1534-41 - PubMed
  9. Rheumatology (Oxford). 2010 Jul;49(7):1406-8 - PubMed
  10. J Rheumatol. 1998 Sep;25(9):1844-50 - PubMed
  11. Best Pract Res Clin Rheumatol. 2002 Jul;16(3):347-60 - PubMed
  12. J Rheumatol. 2004 Feb;31(2):390-2 - PubMed
  13. Bull NYU Hosp Jt Dis. 2006;64(1-2):72-6 - PubMed
  14. Pediatrics. 2002 Jan;109(1):109-15 - PubMed
  15. Lancet. 2007 Mar 3;369(9563):767-778 - PubMed
  16. J Rheumatol. 2012 Sep;39(9):1867-74 - PubMed
  17. Rheumatology (Oxford). 2005 Aug;44(8):995-1001 - PubMed
  18. J Rheumatol. 2007 Aug;34(8):1773-6 - PubMed
  19. Arthritis Care Res (Hoboken). 2011 Apr;63(4):465-82 - PubMed
  20. J Rheumatol. 2011 May;38(5):938-53 - PubMed
  21. Arthritis Rheum. 2008 Nov 15;59(11):1571-9 - PubMed
  22. Arthritis Rheum. 2006 Apr 15;55(2):177-83 - PubMed
  23. J Rheumatol. 2003 Sep;30(9):1900-3 - PubMed
  24. Rheumatol Int. 1994;14(2):53-6 - PubMed
  25. J Rheumatol. 1998 Oct;25(10):1991-4 - PubMed
  26. Clin Exp Rheumatol. 2004 May-Jun;22(3):271-5 - PubMed
  27. Clin Exp Rheumatol. 2001 Jul-Aug;19(4 Suppl 23):S1-9 - PubMed
  28. Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S157-62 - PubMed
  29. Arthritis Rheum. 2012 Jul;64(7):2366-74 - PubMed
  30. Arthritis Rheum. 2009 May 15;61(5):658-66 - PubMed
  31. Arthritis Rheum. 2005 Jul;52(7):2092-102 - PubMed

Publication Types